The retinal phenotype in primary hyperoxaluria type 2 and 3
Johannes Birtel(Universität Hamburg), Peter Charbel Issa(Technical University of Munich), Bodo B. Beck(University of Cologne), Sander F. Garrelfs(Emma Kinderziekenhuis), Sophie Kaspar(Institute of Human Genetics), Roselie M.H. Diederen(Amsterdam University Medical Centers), Philipp Herrmann(University of Bonn), Bernd Höppe(University of Bonn)
Cited by 7
Related Papers
The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4
|Nature Genetics|2006|573
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|505
History, epidemiology and regional diversities of urolithiasis
|Pediatric Nephrology|2008|460
The primary hyperoxalurias
|Kidney International|2009|373
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361